0
Editor's Correspondence |

Prevalence of Parvovirus B19 Infection Among Patients With Human Immunodeficiency Virus Infection in Barcelona, Spain

Eugenia Negredo, MD; Pere Domingo, MD; Nuria Rabella, MD; Joaquín López-Contreras, MD; Angels Fontanet, RN; Inmaculada Orellana, RN
Arch Intern Med. 1998;158(6):680-681. doi:.
Text Size: A A A
Published online

Extract

Anemia is one of the most common hematologic abnormalities in patients with acquired immunodeficiency syndrome, affecting as many as 80% of patients. Opportunistic infections, myelosuppressive drugs (antiretroviral medications, ganciclovir, or cytotoxic chemotherapy), neoplasms, or immunologic changes induced by human immunodeficiency virus (HIV) may contribute to the cause of anemia. Parvovirus B19 (PV B19) is known to cause a pure red cell aplasia through a lysis of erythroid progenitor cells.1 Thus, PV B19 infection is another potential mechanism of anemia in HIV-infected patients. However, there are some controversial points related to PV B19 infection in this population: First, its prevalence in HIV-infected patients is variable and ranges from 10% to 60%24; second, the prevalence of PV B19 infection that causes anemia in HIV-infected individuals26; and third, the ideal diagnostic method for treating PV B19 infection in patients with acquired immunodeficiency syndrome. It has been suggested that serological testing may not be a sensitive diagnostic method because of the poor immunologic response in immunocompromised patients.2,4,7 Thus, the detection of PV B19 nucleic acids using DNA hybridization or polymerase chain reaction has been proposed as the standard diagnostic method.2,4,6,7

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs
brightcove.createExperiences();